Bronchiectasis

January 26, 2015November 6, 2015

COPD and Bronchiectasis: Similarities and Differences

Bronchiectasis

Bronchiectasis and chronic obstructive pulmonary disorder (COPD): synonyms for the same condition? Not quite. The American Thoracic Society defines COPD as “a group of lung conditions that make it difficult ... Read more

January 16, 2015November 6, 2015

Ciprofloxacin Dry Powder for Inhalation Tested in Bronchiectasis

Bronchiectasis, News

Bayer and Novartis, two leading pharmaceutical companies, are developing ciprofloxacin dry powder for inhalation (DPI, brand name Cipro Inhale) to treat non-cystic fibrosis bronchiectasis. A phase 2 clinical trial, “Evaluation ... Read more

January 16, 2015November 6, 2015

Aradigm’s Non-Cystic Fibrosis Bronchiectasis Drug Pulmaquin Granted New Patents in Europe and Australia

Bronchiectasis, News

Aradigm Corporation has announced that it recently obtained two new patents providing coverage for formulations of liposomal and free ciprofloxacin in Europe (E.U. Patent No. 2079443) and Australia (AU2012211514). Both patents cover ... Read more

January 13, 2015November 6, 2015

Quality of Life Questionnaire for Bronchiectasis Tested Alongside Aztreonam

Bronchiectasis, News

Gilead Sciences, a leader in therapeutic development for lung diseases, investigated the use of the Respiratory Domain of the Quality of Life Questionnaire-Bronchiectasis (QOL-B) in evaluating patients taking inhaled aztreonam ... Read more

January 8, 2015November 6, 2015

Bronchiectasis Onset in CF Combatted with Azithromycin

Bronchiectasis, News

To “combat CF” and reduce bronchiectasis onset in the disease, researchers and clinicians at Queensland Children’s Medical Research Institute are currently recruiting patients for the “COMBATCF” clinical trial, “Prevention of ... Read more

December 8, 2014November 6, 2015

Inhaled Aztreonam Shows Positive Results For Non-Cystic Fibrosis Bronchiectasis Patients In Recent Phase 3 Trials

Bronchiectasis, News

A study from a Phase 3 trial on an inhaled antibiotic therapy for non-cystic fibrosis bronchiectasis entitled “Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): ... Read more

December 2, 2014November 6, 2015

Bayer’s Non-cystic Fibrosis Bronchiectasis, Pneumonia Drugs Gain QIDP Status From FDA

Bronchiectasis, News

Recently, two Bayer experimental drugs, Amikacin Inhale and Ciprofloxacin Dry Powder for Inhalation (DPI), were granted the title of qualified infectious disease products (QIDP) by the U.S. Food and Drug Administration ... Read more

November 26, 2014November 6, 2015

New Way of Identifying Bronchiectasis Infection Speeds Time to Recovery

Bronchiectasis, News

When diagnosing bronchiectasis, faster is always better. A faster diagnosis means a faster decision for treatment and often a sooner recovery for the patient. A group of researchers from Peking ... Read more

November 24, 2014November 6, 2015

Recent Asian Bronchiectasis Study Offers Analysis Of Etiology, Focus On Pseudomonas Aeruginosa

Bronchiectasis, News

A study entitled “Analysis Of Etiology And Clinical Manifestations Of Patients With Bronchiectasis In Chinese Adult From Peking Union Medical College Hospital” was published in the American Thoracic Society International ... Read more

November 21, 2014November 6, 2015

Population Based Study Reveals Association Between Bronchiectasis, Cardiovascular Disease

Bronchiectasis, News

An important association between Bronchiectasis and the risk of cardiovascular events was published as an abstract in the American Journal of Respiratory and Critical Care Medicine. The study entitled “The Association Between ... Read more